Grimaila, R. J., Fuller, B. A., Rennert, P. D., Nelson, M. B., Hammarskjöld, M. L., Potts, B., . . . Gray, G. (1992). Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization.

Grimaila, R J., B A. Fuller, P D. Rennert, M B. Nelson, M L. Hammarskjöld, B. Potts, M. Murray, S D. Putney, a G. Gray. Mutations in the Principal Neutralization Determinant of Human Immunodeficiency Virus Type 1 Affect Syncytium Formation, Virus Infectivity, Growth Kinetics, and Neutralization. 1992.

Grimaila, R J., et al. Mutations in the Principal Neutralization Determinant of Human Immunodeficiency Virus Type 1 Affect Syncytium Formation, Virus Infectivity, Growth Kinetics, and Neutralization. 1992.